Litcius/Paper detail

Longevity of anti-spike and anti-nucleocapsid antibodies after COVID-19 in solid organ transplant recipients compared to immunocompetent controls

John Mackay Søfteland, Magnus Gisslén, Jan‐Åke Liljeqvist, Vanda Friman, Emily de Coursey, Kristjan Karason, Jan Ekelund, Marie Felldin, Jesper Magnusson, Seema Baid‐Agrawal, Carin Wallquist, Andreas Schult, Hanna Jacobsson, Anders Bergdahl, Mats Bemark, Lars‐Magnus Andersson, Inger Holm Gunnarsson, Jan Stenström, Susannah Leach

2021American Journal of Transplantation21 citationsDOIOpen Access PDF

Topics & Concepts

MedicineImmunosuppressionAntibodyImmunologyCoronavirus disease 2019 (COVID-19)Immunoglobulin GImmunityImmune systemInternal medicineDiseaseInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19
Longevity of anti-spike and anti-nucleocapsid antibodies after COVID-19 in solid organ transplant recipients compared to immunocompetent controls | Litcius